Pancreatic transplantation: Evaluation and management

Journal of Intensive Care Medicine

Volumn 19, Issue 3, 2004, Pages 127-139

  Zaman, Fahim ^a   Abreo, Kenneth D ^a   Levine, Steven ^a   Maley, Warren ^a   Zibari, Gazi B ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Human; Pancreas transplantation; Perioperative management; Postoperative complication

Indexed keywords

ACICLOVIR; CYTOMEGALOVIRUS ANTIBODY; FLUCONAZOLE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; VALGANCICLOVIR;

DRUG DOSE REGIMEN; EVALUATION; GLUCOSE HOMEOSTASIS; GRAFT INFECTION; GRAFT SURVIVAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS TRANSPLANTATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; METHODOLOGY; POSTOPERATIVE COMPLICATION;

DIABETES MELLITUS, TYPE 1; HUMANS; PANCREAS TRANSPLANTATION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 4644220257     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066604263916     Document Type: Review

References (79)

1. Shapira Z, Yussim A, Mor E. Pancreas transplantation. J Pediatr Endocrinol Metab. 1999;12:3-15.
2. Sutherland DE, Gruessner RW, Gruessner AC. Pancreas transplantation for treatment of diabetes mellitus. World J Surg. 2001;25:487-496.
3. Pancreas transplantation for patients with type 1 diabetes: American Diabetes Association. Diabetes Care. 2000;23:117.
4. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med. 1990;22:1031-1037.
5. Ojo A, Meier-Kriesche HU, Hanson J, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation. 2001;71:82-90.
6. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas and islet transplantation for patients with diabetes. Diabetes Care. 2000;23:112-116.
7. United States Renal Data System. Minneapolis, Minn: USRDS Coordinating Center.
8. Brunkhorst R, Lufft V, Dannenberg D, et al. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study. Transplantation. 2003;76:115-119.
9. Mohan P, Safi K, Little DM, et al. Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg. 2003;90:1137-1141.
10. Becker BN, Brazy PC, Becker YT, et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patient with end-stage renal disease. Kidney Int. 2000;57:2129-2135.
11. Gruessner A, Sutherland DER. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October 2000. Clin Transplant. 2002;41-77.
12. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg. 2001;233:463-501.
13. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas transplantation for patients with type 1 diabetes. Diabetes Care. 2003;26(suppl 1)S120.
14. Kahl A, Bechstein WO, Frei U. Trends and perspectives in pancreas and simultaneous pancreas and kidney transplantation. Curr Opin Urol. 2001;11:165-174.
15. Suresh Kumar KK, Mubin T, Mikhael N, et al. Assessment of quality of life after simultaneous pancreas-kidney transplantation. Am J Kidney Dis. 2002;39:1300-1306.
16. Kiberd B, Larson T. Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: a theoretical analysis. Transplantation. 2000;70:1121.
17. Smets YF, Weatendorp RG, van der Pijl JW, et al. Effects of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end stage renal failure. Lancet. 1999;353:1915-1919.
18. Wideman L, Elahi D, Hanks J. Whole organ transplantation and glucose regulation. World J Surg. 2001;25:516-522.
19. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 1967;61:827-837.
20. Sollinger HW, Oddorico JS, Knechtle SJ, et al. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg. 1998;228:284-296.
21. Stratta RJ, Taylor RJ, Larsen JL, et al. Pancreas transplantation. Int J Pancreatol. 1995;17:1-13.
22. Pirson Y, Vandeleene B, Squifflet JP. Kidney and kidney-pancreas transplantation in diabetic recipients. Diabetes Metab. 2000;26(suppl 4):86-89.
23. Odorico JS, Sollinger HW. Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus. World J Surg. 2002;26:194-211.
24. Krishnamurthi V, Philosophe B, Bartlett ST. Pancreas transplantation: contemporary surgical techniques. Urol Clin North Am. 2001;28:833-838.
25. Sollinger HW, Odorico JS, Knechtle SJ, et al. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg. 1998;228:284-296.
26. Odorico JS, Becker YT, Grosheck M, et al. Improved solitary pancreas transplant graft survival in the modern immunosuppressive era. Cell Transplant. 2000;9:919.
27. Sutherland DE, Gruessner RG, Humar A, et al. Pretransplant immunosuppresion for pancreas transplants alone in nonuremic diabetic recipients. Transplant Proc. 2001;33:1656-1658.
28. Gruessener A, Gruessner R, Munns KM, et al. Influence of multiple factors (age, transplant number, recipient category, donor source) on outcome of pancreas transplantation at one institution. Transplant Proc. 1993;25:1303-1305.
29. Di Carlo V, Castoldi R, Cristallo M, et al. Techniques of pancreas transplantation through the world: an IPITA survey. Transplant Proc. 1998;30:231-241.
30. Fabrega AJ, Rivas PA, Pollack R. Pancreas-kidney transplantation for intensivists: peri-operative care and complications. J Intensive Care Med. 1994;9:281-289.
31. Zibari GB, Boykin KN, Sawaya DE, et al. Pancreatic transplantation and subsequent graft surveillance by pancreatic portal-enteric anastomosis and temporary venting jejunostomy. Ann Surg. 2001;233:639-644.
32. Gaber AO, Shokouh-Amiri MH, Hathaway DK, et al. Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg. 1995;221:613.
33. Gruessner AC, Sutherland DE, Dunn DL, et al. Pancreas after kidney transplants in posturemic patients with type I diabetes mellitus. J Am Soc Nephrol. 2001;12:2490-2499.
34. Robertson RP, Sutherland DE. Pancreas transplantation as therapy for diabetes mellitus. Ann Rev Med. 1992;43:395-415.
35. Zielinski A, Nazarewski S, Bogetti D, et al. Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. Transplantation. 2003;76:547-552.
36. Gruessner RW, Leone JP, Sutherland DE. Combined kidney and pancreas transplants from living donors. Transplant Proc. 1998;30:282.
37. Gruessner RW, Sutherland DE, Drangstveit MB, Bland BJ, Gruessner AC. Pancreas transplants from living donors: short- and long-term outcome. Transplant Proc. 2001;33:819-820.
38. Robertson RP, Sutherland DE, Seaquist ER, Lanz KJ. Glucagon, catecholamine, and symptom responses to hypoglycemia in living donors of pancreas segments. Diabetes. 2003;52:1689-1694.
39. Robertson RP. Prevention of recurrent hypoglycemia in type 1 diabetes by pancreas transplantation. Acta Diabetol. 1999;36:3-9.
40. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes. 2002;51:3428-3434.
41. Hricik DE. Kidney-pancreas transplantation for diabetic nephropathy. Semin Nephrol. 2000;20:188-198.
42. Coppelli A, Giannarelli R, Mariotti R, et al. Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation. 2003;76:974-976.
43. Chow VC, Pai RP, Chapman JR, et al. Diabetic retinopathy after combined kidney-pancreas transplantation. Clin Transplant. 1999;13:356-362.
44. La Rocca E, Fiorina P, Astorri E, et al. Patient survival and cardiovascular events after kidney-pancreas transplantation: comparison with kidney transplantation alone in uremic IDDM patients. Cell Transplant. 2000;9:929-932.
45. Fiorina P, Folli F, Bertuzzi F, et al. Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care. 2003;26:1129-1136.
46. Jukema JW, Smets YF, van der Pijl JW, et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care. 2002;25:906-911.
47. Stratta RJ, Taylor RJ, Wahl TO, et al. Recipient selection and evaluation for vascularized pancreas transplantation. Transplantation. 1993;55:1090-1096.
48. Bennett PH, Rewers MJ, Knowler WC. Epidemiology of diabetes mellitus. In: Porte D Jr, Sherwin RS, Baron A, eds. Ellenberg and Rifkin's Diabetes Mellitus. 6th ed. New York, NY: McGraw-Hill; 2003:277-300.
49. Pirsch JD, Odorico JS, D'Alessandro M, et al. Post-transplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. Transplantation. 1998;66:1746-1750.
50. Eubank WB, Schmied UP, Levy AE, et al. Venous thrombosis and occlusion after pancreas transplantation: evaluation with breath-hold gadolinium-enhanced three-dimensional MR imaging. AJR Am J Roentgenol. 2000;175:381-385.
51. Shoukouh-Amiri H, Egidi MF, Gaber AO, et al. Long term results in pancreatic transplantation according to different anastomotic techniques: a single center experience. Abstract presented at: International Pancreatic and Islet Transplant Association; July 2003; Dublin, Ireland.
52. Boykin K, Zibari GB. Management of complications of simultaneous kidney pancreas transplantation with temporary venting jejunostomy. Clin Transplant. 2003;17(suppl 9):65-68.
53. Zibari GB, Aultman DF, Abreo KD, et al. Roux-en-Y venting jejunostomy in pancreatic transplantation: a novel approach to monitor rejection and prevent anastomotic leak. Clin Transplant. 2000;14:380-385.
54. Drew LW, Limaye A, Singh N. New perspectives on CMV and other viruses in the immunocompromised patient. Clinician. 2003;21:1-18.
55. International Pancreas Transplant Registry. Annual Report for 2002 [newsletter]. Minneapolis, Minn: International Pancreas Transplant Registry.
56. Knight RJ, Bodian C, Rodriguez-Laiz G, Guy SR, Fishbein TM. Risk factors for intra-abdominal infection after pancreas transplantation. Am J Surg. 2000;179:99-102.
57. Hariharan S, Pirsch JD, Lu CY, et al. Pancreas after kidney transplantation. J Am Soc Nephrol. 2002;13:1109-1118.
58. Kuo PC, Johnson LB, Scweitzer J, et al. Solitary pancreas allografts: the role of percutaneous biopsy and standardized histologic grading of rejection. Arch Surg. 1997;132:52-57.
59. Rhandhawa P. Allograft biopsies in management of pancreas transplant recipients. Postgrad Med J. 2002;48:56-63.
60. Woodside KJ, Kasten KR, Ishihara K, Hunter GC, Gugliuzza KK, Daller JA. Portal and systemic drained pancreas transplants have similar outcomes. J Surg Res. 2003;114:281-282.
61. Reddy KS, Davies D, Ormond D, Tuteja S, et al. Impact of acute rejection episodes on long-term graft survival following simultaneous kidney-pancreas transplantation. Am J Transplant. 2003;3:439-444.
62. Knight RJ, Kerman RH, Zela S, et al. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation. Transplantation. 2003;75:1301-1306.
63. Kaufman DB, Iii GW, Bruce DS, et al. Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. Am J Transplant. 2003;3:855-864.
64. Stratta RJ, Alloway RR, Lo A, Hodge E. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study. Transplantation. 2003;75:1260-1266.
65. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-238.
66. Boggi U, Vistoli F, Chiaro M, et al. Single center, open, prospective, randomized study comparing cyclosporine versus tacrolimus in simultaneous pancreas-kidney transplantation. Abstract presented at: International Pancreatic and Islet Transplant Association; July 2003; Dublin, Ireland.
67. Luzi L, Picena Sereni L, Battezzati A, Elli A, et al. Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant. Transplantation. 2003;75:2018-2023.
68. Mayes JT, Dennis VW, Hoogwerf BJ. Pancreas transplantation in type 1 diabetes: hope vs reality. Cleve Clin J Med. 2000;67:281-286.
69. Hakim NS. Recent developments and future prospects in pancreatic and islet transplantation. Diabetes Obes Metab. 2001;3:9-15.
70. Tan M, Cantarovich M, Mangel R, et al. Reduced dose thymoglobulin, tacrolimus, and mofetil mycophenolate results in excellent pancreas transplantation outcomes. Clin Transplant. 2002;16:414-420.
71. Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC. Mycophenolate mofetil in pancreas transplantation. Transplantation. 1998;66:318-323.
72. Gruessner RW, Sutherland DE, Drangstveit MB, West M, Gruessner AC. Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation. Transplant Proc. 1998;30:518-320.
73. Humar A, Ramcharan T, Kandaswamy R, et al. Pancreas after kidney transplants. Am J Surg. 2001;182:155-161.
74. Stratta RJ. Review of immunosuppressive usage in pancreas transplantation. Clin Transplant. 1999;13:1-12.
75. Rogers J, Ashcraft E, Baliga PK, et al. Long term-outcome of sirolimus rescue in kidney-pancreas transplantation. Abstract presented at: International Pancreatic and Islet Transplant Association; July 2003; Dublin, Ireland.
76. White SA, Kimber R, Veitch PS, Nicholson ML. Surgical treatment of diabetes mellitus by islet cell and pancreas transplantation. Postgrad Med J. 2001;77:383-387.
77. Daneman D. Islet cell transplantation and other new technologies for treating type 1 diabetes: a pediatric view. Horm Res. 2002;57(suppl 1):54-59.
78. Dekel B, Burakova T, Arditti FD, et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med. 2003;9:53-60.
79. Pancreas retransplantation in different immunosuppressive eras. Abstract presented at: International Pancreatic and Islet Transplant Association; July 2003; Dublin, Ireland.